跳至主要内容
临床试验/NCT05962580
NCT05962580已完成不适用

of Anterior Cruciate Ligament Reconstruction With and Without Lateral Extra-Articular Tenodesis Between High Demand Patients: Randomized Controlled Trial

Ain Shams University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
failure rate

研究概览

简要总结

Anterior Cruciate Ligament Reconstruction with and without Lateral Extra-Articular Tenodesis between high demand patients

详细描述

It is a randomized control trial comparing between isolated anterior cruciate ligament reconstruction with and without lateral extra articular tenodesis between high demand and high risk groups with high pivot regarding failure rate (primary out come) and patient reported functions score (IKDC and Lysholm)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • High demand patients (manual workers, athletes,...etc.).
  • Normal average body mass index ( 18.5 - 24.9 ).
  • Age <40 years old.
  • Patients will be diagnosed as ACL tear by the following:
  • History of knee traumatic event.
  • Clinical examination ( positive Lachman test and pivot shift test).
  • Radiological evidence of ACL tear by MRI.
  • patient with high pivot shift test.

排除标准

  • Generalized ligamentous laxity.
  • Other intra or extra articular knee injuries.
  • Previous ACL surgery on the affected knee.
  • Bilateral ACL injuries.
  • Significant Articular surface injury.
  • Medical comorbidities
  • Patients with malalignment ( genu varum, genu valgum or genu recurvatum )
  • Neuromuscular disorders
  • Knee arthritic changes.

结局指标

主要结局

failure rate

时间窗: one year follow up

retear of ACL graft confirmed by clinical examination and MRI

次要结局

  • antero-posterior instability measure(at 3,6,9 and 12 months)
  • International knee documentation committee score (IKDC)(at 3,6,9,12 months)
  • Lysholm score(at 3,6,9,12 months)
  • side to side KT 1000 lachmeter difference(one year follow up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验